Your browser doesn't support javascript.
loading
Viral infectivity in pediatric SARS-CoV-2 clinical samples does not vary by age
Madaline M Schmidt; Hannah W Despres; David J Shirley; Michael E Bose; Kate C McCaul; Jessica W Crothers; Kelly J Henrickson; Benjamin Lee; Emily A Bruce.
Afiliação
  • Madaline M Schmidt; University of Vermont
  • Hannah W Despres; University of Vermont
  • David J Shirley; Faraday, Inc
  • Michael E Bose; Medical College of Wisconsin
  • Kate C McCaul; Medical College of Wisconsin
  • Jessica W Crothers; University of Vermont
  • Kelly J Henrickson; Medical College of Wisconsin
  • Benjamin Lee; University of Vermont
  • Emily A Bruce; University of Vermont
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22281193
ABSTRACT
During the early months of the SARS-CoV-2 pandemic, notable uncertainty emerged regarding the role of children in transmission dynamics 1. With time, it became more clear that children were susceptible to infection with SARS-CoV-2, but that the vast majority of children experienced mild symptoms with lower incidence of severe disease 2. This pattern remained consistent despite the later emergence of SARS-CoV-2 variants, including Delta and Omicron, even among children <5 ineligible for vaccination3. The relative lack of severe disease in the pediatric population raised questions regarding viral kinetics and infectivity in children versus adults.
Licença
cc_by_nc_nd
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint